Stocks and securities in focus
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ardelyx Inc. | 28.120% | 34.723% | 16.633% | 93.717% | 39.758% | 44.250% | - |
Twist Bioscience Corp | 27.860% | 29.861% | 27.227% | 226.536% | 10.799% | -58.193% | - |
Gritstone Oncology Inc | 13.680% | 16.156% | -0.447% | -60.985% | -52.018% | -87.408% | - |
X4 Pharmaceuticals, Inc. | 5.830% | -1.469% | -15.512% | -30.325% | 37.564% | - | - |
Akebia Therapeutics Inc. | 5.260% | 2.324% | -6.856% | 32.058% | 8.959% | -50.117% | - |
Coherus Bioscien. | 4.310% | 10.673% | -5.985% | -68.250% | -30.757% | -82.746% | -85.702% |
Heron Therapeutics Inc. | 4.300% | 5.493% | -4.499% | 19.802% | 54.140% | -82.733% | - |
Evolus Inc | 4.240% | 17.143% | 2.500% | 61.842% | 35.912% | 68.493% | - |
Anika Therapeutics | 4.070% | 7.563% | 6.667% | 9.402% | 25.490% | -24.260% | -17.192% |
Sangamo Therapeutics Inc. | 3.900% | 5.702% | -1.250% | -57.625% | -10.711% | -94.059% | -95.005% |
Actinium Pharmaceuticals Inc. | 1.290% | 28.594% | -5.859% | 3.438% | 83.075% | 33.468% | - |
Viking Therapeutics Inc | 1.050% | 2.938% | 1.419% | 244.648% | 308.808% | 1354.323% | - |
Cytomx Therapeutics Inc | -0.190% | 174.933% | 116.369% | 167.792% | 195.415% | -41.915% | - |
Medigene AG | -0.630% | 2.303% | -27.674% | -10.888% | -2.201% | -60.831% | -82.538% |
AnaptysBio Inc | -0.810% | 26.154% | 27.461% | 24.242% | 26.804% | 17.143% | - |
Deciphera Pharmaceuticals | -0.850% | 74.436% | 68.116% | 91.183% | 57.877% | -34.831% | - |
Biocryst Pharmaceuticals | -1.220% | 6.102% | -3.035% | -46.798% | -25.533% | -53.624% | -39.530% |
Geron Corp. | -1.390% | 3.081% | 18.833% | 46.348% | 85.315% | 220.756% | 131.556% |
Intra-Cellular Therapies Inc. | -3.030% | -7.246% | 0.787% | 13.879% | -1.840% | 140.421% | 408.744% |
Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
Durect Corp. | -8.040% | - | - | - | - | - | - |
Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
Adamas Pharmaceuticals Inc. | - | - | - | - | - | - | - |